| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 37 |
| 1 | ADALIMUMAB | 35 |
| 2 | INFLIXIMAB | 34 |
| 3 | ESTRADIOL | 33 |
| 4 | PREDNISONE | 33 |
| 5 | METHYLPREDNISOLONE | 32 |
| 6 | LEVONORGESTREL | 31 |
| 7 | USTEKINUMAB | 30 |
| 8 | PREDNISOLONE | 29 |
| 9 | PREDNISOLONE ORAL | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LINCOMYCIN HYDROCHLORIDE | 2 | 0.0068 |
| 1 | RALTEGRAVIR | 25 | 0.0048 |
| 2 | MIRIKIZUMAB-MRKZ | 3 | 0.0033 |
| 3 | BETAMETHASONE DIPROPIONATE | 16 | 0.0024 |
| 4 | TOFACITINIB CITRATE | 29 | 0.0022 |
| 5 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 2 | 0.0017 |
| 6 | MERCAPTOPURINE | 24 | 0.0014 |
| 7 | DESOXIMETASONE | 25 | 0.0013 |
| 8 | MESALAMINE | 27 | 0.0010 |
| 9 | PILOCARPINE HYDROCHLORIDE | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 55 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 45 |
| 2 | Estrogen [EPC] | 44 |
| 3 | Integrin Receptor Antagonist [EPC] | 37 |
| 4 | Progestin [EPC] | 35 |
| 5 | Progestin-containing Intrauterine System [EPC] | 31 |
| 6 | Interleukin-12 Antagonist [EPC] | 30 |
| 7 | Interleukin-23 Antagonist [EPC] | 30 |
| 8 | Aminosalicylate [EPC] | 29 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 1 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 2 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 3 | Integrin Receptor Antagonist [EPC] | 37 | 0.0004 |
| 4 | Copper-containing Intrauterine Device [EPC] | 19 | 0.0004 |
| 5 | Cephalosporin Antibacterial [EPC] | 3 | 0.0003 |
| 6 | Interleukin-12 Antagonist [EPC] | 30 | 0.0003 |
| 7 | Aminosalicylate [EPC] | 29 | 0.0003 |
| 8 | Interleukin-23 Antagonist [EPC] | 30 | 0.0003 |
| 9 | Estrogen [EPC] | 44 | 0.0002 |